99 related articles for article (PubMed ID: 7714611)
41. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
42. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
Shir A; Ogris M; Wagner E; Levitzki A
PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
[TBL] [Abstract][Full Text] [Related]
43. Action of epidermal growth factor and retinoids on anchorage-dependent and -independent growth of nontransformed rat kidney cells.
Jetten AM; Goldfarb RH
Cancer Res; 1983 May; 43(5):2094-9. PubMed ID: 6299539
[TBL] [Abstract][Full Text] [Related]
44. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
45. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
46. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
47. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth.
Laterra J; Rosen E; Nam M; Ranganathan S; Fielding K; Johnston P
Biochem Biophys Res Commun; 1997 Jun; 235(3):743-7. PubMed ID: 9207232
[TBL] [Abstract][Full Text] [Related]
48. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2.
Martens T; Laabs Y; Günther HS; Kemming D; Zhu Z; Witte L; Hagel C; Westphal M; Lamszus K
Clin Cancer Res; 2008 Sep; 14(17):5447-58. PubMed ID: 18765536
[TBL] [Abstract][Full Text] [Related]
50. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.
Lund-Johansen M; Bjerkvig R; Humphrey PA; Bigner SH; Bigner DD; Laerum OD
Cancer Res; 1990 Sep; 50(18):6039-44. PubMed ID: 2393868
[TBL] [Abstract][Full Text] [Related]
51. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme.
Canute GW; Longo SL; Longo JA; Shetler MM; Coyle TE; Winfield JA; Hahn PJ
Neurosurgery; 1998 Mar; 42(3):609-16. PubMed ID: 9526995
[TBL] [Abstract][Full Text] [Related]
52. Loss of response to epidermal growth factor and retinoic acid accompanies the transformation of human prostatic epithelial cells to tumorigenicity with v-Ki-ras.
Peehl DM; Wong ST; Sellers RG; Jin S; Rhim JS
Carcinogenesis; 1997 Aug; 18(8):1643-50. PubMed ID: 9276642
[TBL] [Abstract][Full Text] [Related]
53. [EGFR expression and EGF stimulation of proliferation in human liver carcinoma cells].
Xu YH; Jiang WL; Peng SF
Shi Yan Sheng Wu Xue Bao; 1989 Dec; 22(4):445-53. PubMed ID: 2560604
[TBL] [Abstract][Full Text] [Related]
54. Growth inhibition of epidermal growth factor-stimulated human glioblastoma cells by nicardipine in vitro.
Huang C; Hu S; Chen B
J Neurosurg Sci; 2001 Sep; 45(3):151-5. PubMed ID: 11731739
[TBL] [Abstract][Full Text] [Related]
55. Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.
O'Rourke DM; Qian X; Zhang HT; Davis JG; Nute E; Meinkoth J; Greene MI
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3250-5. PubMed ID: 9096379
[TBL] [Abstract][Full Text] [Related]
56. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo.
Takamiya Y; Brem H; Ojeifo J; Mineta T; Martuza RL
Neurosurgery; 1994 May; 34(5):869-75; discussion 875. PubMed ID: 8052385
[TBL] [Abstract][Full Text] [Related]
57. Effects of epidermal growth factor, fibroblast growth factor, retinoic acid and serum on anchorage-dependent and anchorage-independent growth of HRRT cells.
Eker P
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):499-504. PubMed ID: 2784762
[TBL] [Abstract][Full Text] [Related]
58. Glioblastoma-associated circulating monocytes and the release of epidermal growth factor.
Fries G; Perneczky A; Kempski O
J Neurosurg; 1996 Oct; 85(4):642-7. PubMed ID: 8814168
[TBL] [Abstract][Full Text] [Related]
59. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa R; Ji XD; Harmon RC; Lazar CS; Gill GN; Cavenee WK; Huang HJ
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7727-31. PubMed ID: 8052651
[TBL] [Abstract][Full Text] [Related]
60. Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.
Berens ME; Rief MD; Shapiro JR; Haskett D; Giese A; Joy A; Coons SW
J Neurooncol; 1996 Jan; 27(1):11-22. PubMed ID: 8699221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
